If you or your family have health problems related to testosterone-replacement medications, it’s important that you keep up with ongoing news of pending litigation. Most recently, an AndroGel MDL was created by a Judicial Panel on Multidistrict Litigation.
On June 6, 2014, the MDL panel made and filed its decision. All Testosterone cases will be united under MDL No. 2545, U.S. District Court, Northern District of Illinois. But what does that mean to you?
A more efficient litigation process
The MDL panel decision resulted in the transfer order entitled “In re: AndroGel Products Liability Litigation- MDL No. 2545.” It requires that all Testosterone lawsuits involving all manufacturers of the drug be centralized in one location, before a single federal judge. The order also changed the 2545 case caption to “Testosterone Replacement Therapy Products Liability Litigation.”
It’s a decision that will allow the legal discovery for the body of cases to flow more smoothly and efficiently. The move will benefit Testosterone plaintiffs for many reasons.
Common questions of fact can be answered at the same time
AndroGel, Axiron, and similar products were used by millions of men to relieve energy, libido, and other problems associated with male aging. Numerous lawsuits have been filed as a result.
As the drug was widely prescribed, there’s a potential for lawsuits in multiple local and federal courts across the country. Traditionally, each separate lawsuit or class action would have its own expensive schedule. The individual outcomes of those suits might or might not affect other pending cases.
Centralizing the Testosterone litigation will allow the common questions to be presented and answered for all cases at once, instead of on a case by case basis. The answers to common questions–did the drug cause injury, did the manufacturers know about it, did they hide the problem–should be more consistent than if the cases were heard in different jurisdictions.
Plaintiffs and defendants will save discovery costs
Discovery can be expensive. For drug cases it may involve depositions from key drug company witnesses, expert reports, witness testimony, and much more. As these cases may ultimately involve numerous plaintiffs and attorneys, each deposition of a witness or production of documents could potentially involve multiple attorney, clerk, court reporter, and transcription hours at an exorbitant cost.
When all common cases are consolidated against the same defendants, ideally, a court need only ask the defendants a series of questions on a one time basis, instead of numerous times depending on the cases and jurisdictions. Minimizing discovery this way will minimize expenses and help to move all the cases along more rapidly.
Reduce inconvenience to plaintiffs
Men who used testosterone-replacement therapies developed an increased risk of heart attacks and strokes. The women and children in their families–who could be contaminated by a simple hug–suffered from premature puberty, enlarged breasts, aggression, excess hair, and many other problems. They don’t need the additional inconvenience of ongoing trials.
Centralization of the entire body of cases should speed up the process. It’s a fair move that will likely help injured plaintiffs get the justice they deserve, sooner rather than later.
If you were injured by testosterone-therapy drugs
If you or anyone you know were injured by using or coming into contact with testosterone-therapy drugs prescribed for the condition “Low-T,” you may be entitled to damages.
The court cases are now organized in a single jurisdiction. That should make the process easier to work through, but you must file your case before your statute of limitations expires.
If you’d like more information about the Testosterone cases, contact AndroGel Lawyers. We can help.